Company

Mevia AB

Mevia AB develops connected devices and data tools that track medication adherence in clinical trials.

About

Founded in 2014 and based in Gothenburg, Sweden, Mevia AB offers end-to-end solutions for medication adherence and secure data management in clinical trials. Its Mepill and Medose devices connect to medication packages, record when a dose is taken and show adherence data on a digital dashboard. Clients include pharmaceutical companies and healthcare providers, with partners Merck KGaA and Jones Healthcare Group. Revenue for 2024 was SEK 201,759.90. The company raised SEK 4.5 million from ALMI Invest, Chalmers Ventures and Spira Invest AB on September 30, 2019.

1Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in